vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Northfield Bancorp, Inc. (NFBK). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $41.3M, roughly 1.5× Northfield Bancorp, Inc.). Cytek Biosciences, Inc. runs the higher net margin — -70.9% vs -1545.5%, a 1474.6% gap on every dollar of revenue. On growth, Northfield Bancorp, Inc. posted the faster year-over-year revenue change (12.7% vs 8.1%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 15.0%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.
CTKB vs NFBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $41.3M |
| Net Profit | $-44.1M | $-27.4M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | -1263.3% |
| Net Margin | -70.9% | -1545.5% |
| Revenue YoY | 8.1% | 12.7% |
| Net Profit YoY | -557.1% | -343.6% |
| EPS (diluted) | — | $-0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $41.3M | ||
| Q3 25 | $52.3M | $39.2M | ||
| Q2 25 | $45.6M | $38.9M | ||
| Q1 25 | $41.5M | $34.8M | ||
| Q4 24 | $57.5M | $36.7M | ||
| Q3 24 | $51.5M | $31.8M | ||
| Q2 24 | $46.6M | $31.5M | ||
| Q1 24 | $44.9M | $31.3M |
| Q4 25 | $-44.1M | $-27.4M | ||
| Q3 25 | $-5.5M | $10.8M | ||
| Q2 25 | $-5.6M | $9.6M | ||
| Q1 25 | $-11.4M | $7.9M | ||
| Q4 24 | $9.6M | $11.3M | ||
| Q3 24 | $941.0K | $6.5M | ||
| Q2 24 | $-10.4M | $6.0M | ||
| Q1 24 | $-6.2M | $6.2M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | -1263.3% | ||
| Q3 25 | -17.6% | 37.7% | ||
| Q2 25 | -23.3% | 35.6% | ||
| Q1 25 | -36.1% | 31.0% | ||
| Q4 24 | 5.2% | 38.0% | ||
| Q3 24 | -8.2% | 27.9% | ||
| Q2 24 | -18.3% | 29.1% | ||
| Q1 24 | -23.9% | 27.2% |
| Q4 25 | -70.9% | -1545.5% | ||
| Q3 25 | -10.5% | 27.4% | ||
| Q2 25 | -12.2% | 24.6% | ||
| Q1 25 | -27.5% | 22.6% | ||
| Q4 24 | 16.8% | 30.7% | ||
| Q3 24 | 1.8% | 20.5% | ||
| Q2 24 | -22.4% | 18.9% | ||
| Q1 24 | -13.8% | 19.9% |
| Q4 25 | — | $-0.68 | ||
| Q3 25 | — | $0.27 | ||
| Q2 25 | — | $0.24 | ||
| Q1 25 | — | $0.19 | ||
| Q4 24 | — | $0.27 | ||
| Q3 24 | — | $0.16 | ||
| Q2 24 | — | $0.14 | ||
| Q1 24 | — | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $164.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $690.1M |
| Total Assets | $461.5M | $5.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $164.0M | ||
| Q3 25 | $93.3M | $131.7M | ||
| Q2 25 | $75.5M | $97.6M | ||
| Q1 25 | $95.3M | $101.7M | ||
| Q4 24 | $98.7M | $167.7M | ||
| Q3 24 | $162.3M | $232.9M | ||
| Q2 24 | $177.9M | $153.5M | ||
| Q1 24 | $168.8M | $238.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $666.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $341.7M | $690.1M | ||
| Q3 25 | $378.6M | $719.6M | ||
| Q2 25 | $377.6M | $710.3M | ||
| Q1 25 | $379.6M | $711.1M | ||
| Q4 24 | $395.7M | $704.7M | ||
| Q3 24 | $385.5M | $699.6M | ||
| Q2 24 | $389.1M | $693.0M | ||
| Q1 24 | $392.6M | $698.4M |
| Q4 25 | $461.5M | $5.8B | ||
| Q3 25 | $494.9M | $5.7B | ||
| Q2 25 | $493.3M | $5.7B | ||
| Q1 25 | $482.6M | $5.7B | ||
| Q4 24 | $499.5M | $5.7B | ||
| Q3 24 | $491.2M | $5.7B | ||
| Q2 24 | $483.7M | $5.7B | ||
| Q1 24 | $492.1M | $5.9B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.95× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $53.7M |
| Free Cash FlowOCF − Capex | $-1.8M | $52.5M |
| FCF MarginFCF / Revenue | -2.9% | 127.1% |
| Capex IntensityCapex / Revenue | 1.6% | 2.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $89.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $53.7M | ||
| Q3 25 | $-3.9M | $13.9M | ||
| Q2 25 | $108.0K | $14.1M | ||
| Q1 25 | $-125.0K | $9.4M | ||
| Q4 24 | $2.0M | $31.1M | ||
| Q3 24 | $13.2M | $14.0M | ||
| Q2 24 | $6.2M | $6.9M | ||
| Q1 24 | $4.0M | $4.2M |
| Q4 25 | $-1.8M | $52.5M | ||
| Q3 25 | $-4.6M | $13.6M | ||
| Q2 25 | $-1.5M | $13.9M | ||
| Q1 25 | $-974.0K | $9.2M | ||
| Q4 24 | $1.1M | $30.0M | ||
| Q3 24 | $12.2M | $13.7M | ||
| Q2 24 | $5.2M | $6.7M | ||
| Q1 24 | $3.4M | $3.8M |
| Q4 25 | -2.9% | 127.1% | ||
| Q3 25 | -8.7% | 34.6% | ||
| Q2 25 | -3.2% | 35.7% | ||
| Q1 25 | -2.3% | 26.3% | ||
| Q4 24 | 1.9% | 81.6% | ||
| Q3 24 | 23.7% | 43.2% | ||
| Q2 24 | 11.0% | 21.1% | ||
| Q1 24 | 7.6% | 12.1% |
| Q4 25 | 1.6% | 2.8% | ||
| Q3 25 | 1.3% | 0.8% | ||
| Q2 25 | 3.5% | 0.6% | ||
| Q1 25 | 2.0% | 0.7% | ||
| Q4 24 | 1.6% | 3.1% | ||
| Q3 24 | 2.0% | 0.7% | ||
| Q2 24 | 2.3% | 0.8% | ||
| Q1 24 | 1.3% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.29× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | 0.21× | 2.76× | ||
| Q3 24 | 14.05× | 2.14× | ||
| Q2 24 | — | 1.16× | ||
| Q1 24 | — | 0.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
NFBK
Segment breakdown not available.
